Melatonin Receptor Agonists: New Options for Insomnia and Depression Treatment

Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models

(2010) Shao-wen Tian et al.   ACTA PHARMACOLOGICA SINICA

Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT1 melatoninergic ligands

(2010) Christophe Mésangeau et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Synthesis of substituted N-[3-(3-methoxyphenyl)propyl] amides as highly potent MT2-selective melatonin ligands

(2010) Yueqing Hu et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Subtyping Major Depressive Disorder

(2010) Pesach Lichtenberg et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Pharmacology of Ramelteon, a Selective MT1/MT2Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders

(2009) Masaomi Miyamoto   CNS Neuroscience & Therapeutics

Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene

(2009) H. Mulder et al.   DIABETOLOGIA

Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment

(2009) Fedor Simko et al.   JOURNAL OF PINEAL RESEARCH

Melatonin: A hormone that modulates pain

(2009) Mónica Ambriz-Tututi et al.   LIFE SCIENCES

Neuroprotection by Radical Avoidance: Search for Suitable Agents

(2009) Rüdiger Hardeland   MOLECULES

Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat

(2009) Simon P. Fisher et al.   NEUROSCIENCE LETTERS

Melatonin modulates visual function and cell viability in the mouse retina via the MT1 melatonin receptor

(2009) K. Baba et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Bidirectional communication between sleep and circadian rhythms and its implications for depression: Lessons from agomelatine

(2009) Seithikurippu R. Pandi-Perumal et al.   PROGRESS IN NEUROBIOLOGY

Effect of exogenous melatonin on the ovary, the embryo and the establishment of pregnancy in sheep

(2008) J. A. Abecia et al.   Animal

Synthesis of 3-phenylnaphthalenic derivatives as new selective MT2 melatoninergic ligands

(2008) Sophie Poissonnier-Durieux et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?

(2008) R Jockers et al.   BRITISH JOURNAL OF PHARMACOLOGY

Melatonin Receptor Agonists: SAR and Applications to the Treatment of Sleep-Wake Disorders

(2008) Silvia Rivara et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

A Double-Blind Comparison of Sexual Functioning, Antidepressant Efficacy, and Tolerability Between Agomelatine and Venlafaxine XR

(2008) Sidney H. Kennedy et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials

(2008) Shantha MW Rajaratnam et al.   LANCET

A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk

(2008) Nabila Bouatia-Naji et al.   NATURE GENETICS